CTLT
Catalent Inc · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website catalent.com
- Employees(FY) 18000
- ISIN US1488061029
Performance
-0.94%
1W
-2.1%
1M
-1.59%
3M
+65.76%
6M
+24.22%
YTD
+66.15%
1Y
Profile
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies; pDNA, iPSCs, oncolytic viruses, and vaccines; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The Pharma and Consumer Health segment offers formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations; and oral, nasal, inhaled, and topical dose forms. This segment also provides clinical supply services through manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials; and pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for softgel capsule, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions; fill and finish operations for injectable products; and integrated development and product supply chain solutions. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was founded in 1933 and is headquartered in Somerset, New Jersey.
Investment Analysis Report: CTLT
Overview
CTLT, a company in the Health Technology sector specializing in Pharmaceuticals, has shown mixed financial performance over the past three years. In this report, we will analyze CTLT's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and capital expendi...
Technical Analysis of CTLT 2024-05-10
Overview:
In analyzing the technical indicators for CTLT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysi...
Recent News & Updates
- 2024-05-10 01:31
- 2024-05-09 13:31
- 2024-05-09 04:15
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results(Businesswire)
- 2024-05-09 01:05
Decoding Catalent Inc (CTLT): A Strategic SWOT Insight(GuruFocus.com)
- 2024-05-09 00:53
- 2024-05-08 23:37
Analyst Report: Catalent, Inc.(Morningstar Research)
- 2024-05-08 19:30
- 2024-05-08 18:24
Catalent: Fiscal Q3 Earnings Snapshot(Associated Press Finance)
- 2024-05-08 16:15
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results(Business Wire)
- 2024-05-03 10:12
Catalent, Novo Nordisk Antitrust Review Extended by FTC(MT Newswires)
- 2024-05-03 09:50
FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal(The Wall Street Journal)
- 2024-05-03 08:16
- 2024-05-03 04:17
How Novo-Catalent Deal Affects Halozyme (HALO)?(Insider Monkey)
- 2024-05-03 04:02
- 2024-05-02 23:31
- 2024-05-02 20:58
- 2024-05-02 20:36
- 2024-05-02 16:17
How Novo-Catalent Deal Affects Halozyme (HALO)?(Insidermonkey)
- 2024-05-02 16:02
- 2024-05-02 10:44
- 2024-05-02 06:18
- 2024-05-01 20:19
- 2024-05-01 20:02
5 Things to Know Before the Stock Market Opens(Investopedia)
- 2024-04-25 11:40
- 2024-04-17 08:19
- 2024-04-16 21:53
Citigroup Inc. (NYSE:C) Q1 2024 Earnings Call Transcript(Insidermonkey)
- 2024-04-11 09:10
- 2024-04-10 14:21
- 2024-04-10 11:03
- 2024-04-08 06:31
Page 1 of 8
previousnext